Wiener Privatklinik (WPK)
Wiener Privatklinik (WPK)
Austria, Vienna
Fritz Leutmezer
27 years of experience
Clinic is certified :
Multiple sclerosis treatment cost in Austria runs from $200 to $300 for a consultation with an ophthalmologist, while specialized treatments like Ocrevus (ocrelizumab) range from $35,000 to $45,000. Total expenses depend on the disease stage, specific medication protocols, and the need for intensive rehabilitation. Austria offers approximately 20-40% savings compared to the United States. Top cities for MS management include Vienna and Lassnitzhoehe.
Typical Multiple Sclerosis Treatment Costs in Austria
Bookimed Expert Insight: Patients requiring complex therapy benefit from specialists like Professor Fritz Leutmezer at Wiener Privatklinik. His expertise in shaping European MS treatment standards ensures high-level diagnostic accuracy. For intensive recovery, Private Hospital Lassnitzhöhe is ideal. Its ISO-certified neurological rehabilitation facility features 289 beds and an indoor pool. Vienna General Hospital (AKH) offers immense clinical resources with its "city in a city" concept.
| Turkey | Austria | Spain | |
| Plasmapheresis | from $1,200 | from $2,000 | from $1,800 |
| Ocrevus (ocrelizumab) | from $10,000 | from $35,000 | from $25,000 |
| Multiple sclerosis rehabilitation | from $3,000 | from $10,000 | from $10,000 |
| Medication treatment for multiple sclerosis | from $2,500 | from $2,000 | from $3,000 |
| Therapeutic Apheresis | from $1,350 | - | - |
Professor Fritz Leutmezer has contributed to European MS treatment guidelines and led clinical trials shaping modern therapy standards at Wiener Privatklinik.
Dr. Fritz Leutmezer leads Austria's Multiple Sclerosis Society and has published 60+ neurology papers. He treats MS at Vienna General Hospital.
Dr. Natalia Hauser specializes in the diagnosis and treatment of Multiple sclerosis at Döbling Private Hospital.
Dr. Klaus Novak is a neurosurgeon at Döbling Private Hospital in Vienna. He introduced intraoperative motor evoked potential monitoring to Austria. This technique improves patient safety during complex nerve surgeries. Dr. Novak specializes in spine surgery and brain tumor treatment. He completed clinical research at Beth Israel Hospital in the United States.
Austrian neurologists no longer treat interferon-beta as the exclusive first-line therapy for multiple sclerosis. While still used for stable cases, clinicians now frequently prescribe high-efficacy disease-modifying therapies (DMTs) upfront. This early intensive strategy helps prevent permanent neurological damage in patients with highly active disease.
Bookimed Expert Insight: Data from major Austrian centers like Vienna General Hospital (AKH) and Wiener Privatklinik shows a shift toward university-linked care. Specialists there often serve as university professors. They can access the latest DMTs through clinical trials before they become standard pharmacy stock. Patients diagnosed at these high-volume hubs may receive high-efficacy protocols faster than at smaller regional facilities.
Patient Consensus: Patients note that Austrian doctors prioritize quick diagnostic rounds to start treatment immediately. Many emphasize that while injections are still offered, the option for infusions once or twice yearly is now common.
Certified Multiple Sclerosis centers established by the Austrian Society of Neurology authorize advanced Disease-Modifying Therapies. Leading institutions include Medical University of Vienna and Innsbruck. These centers actively participate in international clinical trials. They monitor long-term safety through the Austrian MS Therapy Registry.
Bookimed Expert Insight: Patient volume impacts clinical expertise in Austria. Vienna General Hospital (AKH) serves 595,000 patients annually. This high volume allows doctors like Dr. Fritz Leutmezer to lead international trials. He has published over 60 scientific papers on neuroinflammatory disorders. Choosing these high-capacity academic centers ensures access to the latest EMA-approved protocols.
Patient Consensus: Patients recommend prioritizing Vienna for the newest treatments and clinical trial opportunities. They suggest using clinicaltrials.gov to find open spots in local studies before they fill up.
Higher-risk multiple sclerosis therapies in Austria require mandatory screening for HIV, hepatitis B/C, and tuberculosis. Patients must confirm varicella zoster virus immunity before starting. Ongoing monitoring includes regular blood counts, liver function tests, and JC virus antibody indexing to manage infection and autoimmunity risks.
Bookimed Expert Insight: Clinical data from Vienna General Hospital (AKH) and Wiener Privatklinik shows that top Austrian neurologists like Dr. Fritz Leutmezer prioritize complex diagnostics. This includes optical coherence tomography and evoked potentials alongside standard bloodwork. Choosing a center with consolidated university research ensures your monitoring aligns with the latest European MS treatment guidelines.
Patient Consensus: Patients note that monitoring fatigue is real due to constant bloodwork. They emphasize that understanding your JC virus index early helps clarify long-term safety protocols.
Patients receiving Disease-Modifying Therapies (DMTs) in Austria typically plan stays from 1 to 14 days. Infusion therapies like Ocrelizumab require a 7-day to 14-day stay for observation. Standard protocols then mandate clinical follow-up every 3 to 6 months to ensure safety and treatment efficacy.
Bookimed Expert Insight: While many plan for a quick trip, Austrian specialists like Dr. Fritz Leutmezer at Wiener Privatklinik often require a 10-day buffer. This timeframe accounts for pre-treatment bloodwork and post-infusion allergy watches. This is crucial because Vienna General Hospital (AKH) serves over 595,000 patients annually, making scheduling flexibility essential for international cases.
Patient Consensus: Patients note it is important to budget an extra week nearby for bloodwork. Some mention that unexpected drops in blood counts can extend stays to 3 weeks.
Patients starting high-efficacy multiple sclerosis immunotherapy in Austria must update vaccinations and screen for chronic infections. Inactivated vaccines require administration 14 days before therapy. Screening for Hepatitis B, Tuberculosis, and HIV is mandatory. Live-attenuated vaccines are contraindicated during active treatment due to safety risks.
Bookimed Expert Insight: Patients at Wiener Privatklinik benefit from protocols led by Dr. Fritz Leutmezer, President of the Austrian Multiple Sclerosis Society. His expertise ensures vaccination schedules align with the latest European MS treatment guidelines. This specialized oversight is critical for managing complex B-cell depleting therapies like Ocrevus (ocrelizumab).
Patient Consensus: Patients emphasize testing for Varicella-Zoster Virus and Hepatitis B immunity immediately. Many note that bringing complete vaccination records to the first neurology visit prevents treatment delays.
Pregnant or nursing women in Austria can continue specific disease-modifying therapies (DMTs) under strict medical supervision. First-line injectables like Interferon-beta and Glatiramer acetate are generally considered safe. Standardized reproductive counseling at MS centers helps manage medication washouts and transition periods to ensure maternal and fetal safety.
Bookimed Expert Insight: Patient volume data highlights Vienna as the primary hub for complex MS care. Vienna General Hospital (AKH) serves 595,000 patients annually. Its neurologist, Dr. Fritz Leutmezer, is the President of the Austrian MS Society and co-authored the national treatment guidelines. Choosing a specialist who literally wrote the reproductive protocols ensures your washout plan aligns with the most recent safety data.
Patient Consensus: Patients emphasize the need for a personalized reproductive roadmap at every visit. Many suggest planning at least 6 months ahead for high-risk DMT transitions and preparing for quick medication restarts after weaning.
Austrian clinics provide specialized international departments to support non-German speakers through multiple sclerosis treatment. Facilities like Wiener Privatklinik offer multilingual environments. Dedicated coordinators manage medical visa documentation, record reviews, and cost estimates. Personal patient managers often bridge the language gap during infusions and recovery.
Bookimed Expert Insight: While large institutions like Vienna General Hospital (AKH) serve 595,000 patients annually, private clinics often provide more direct linguistic support. Wiener Privatklinik and Döbling Private Hospital maintain lower patient volumes to focus on one-on-one coordination. This structure ensures that international patients receive dedicated attention from the 400+ physicians available in these specialized centers.
Patient Consensus: Patients note that while some nurses use basic English, having a translation app or requesting an international coordinator early helps clarify detailed medical forms. Many find that follow-up care is much smoother when using video consultations or dedicated email support from the hospital's international office.
Modern Disease-Modifying Therapies (DMTs) are widely available in Austria through a network of over 100 certified centres. High-efficacy treatments like Ocrevus (ocrelizumab) and Natalizumab are standard options. Specialist neurologists in Vienna and Graz frequently lead international clinical trials. This provides early access to emerging biological therapies.
Bookimed Expert Insight: Austria's MS care is exceptionally academic. Top specialists like Dr Fritz Leutmezer serve as President of the Austrian Multiple Sclerosis Society. Many leading neurologists at Wiener Privatklinik are also professors at the Medical University of Vienna. This link between clinics and research means patients receive treatment informed by clinical trials.
Patient Consensus: Patients in Austria note that high-efficacy drugs are readily available. However, they must confirm if specialist approval or prior treatment records are required. They recommend choosing a dedicated MS centre over a general practice for modern dosing schedules.
Leading medical facilities for Multiple Sclerosis in Austria include high-ranking institutions like Wiener Privatklinik and Vienna General Hospital. These centres specialise in disease-modifying therapies, plasmapheresis, and MRI diagnostics. Patients access experts who lead international clinical trials and use JCI safety standards.
Bookimed Expert Insight: Austria's private hospitals share senior medical staff with the country's top university. Over 400 physicians at Wiener Privatklinik also serve as professors at the Medical University of Vienna. This provides private-sector comfort alongside research-based treatment for multiple sclerosis.
Patient Consensus: Patients value the multilingual environment in Vienna clinics. They praise the high level of coordination during their medical journey. Finding the clinic entrance can be tricky, so check address details carefully for a smooth first appointment.
Univ. Prof. Dr Fritz Leutmezer and Dr Natalia Hauser are prominent multiple sclerosis specialists in Austria. These neurologists practise at leading Vienna centres. They focus on diagnostics like brain MRI with contrast and Ocrevus treatment. Their work shapes European MS treatment guidelines.
Bookimed Expert Insight: Top Austrian MS specialists often hold dual roles at university hospitals and private clinics. Dr Fritz Leutmezer consults at Wiener Privatklinik and researches at the Medical University of Vienna. Patients get academic-level expertise within a faster, more personalised private setting.
Patient Consensus: Patients note that Vienna clinics offer a multilingual environment and high standards. They recommend double-checking clinic addresses in Austria before appointments to avoid navigation delays.
International patients access experimental Multiple Sclerosis protocols and stem cell therapies in Vienna through accredited hospital networks. Access follows strict European Union regulations. Autologous haematopoietic stem cell transplantation remains the primary evidence-based pathway. Clinical trials require specific eligibility based on disease activity.
Bookimed Expert Insight: Vienna's MS landscape is unique. Leading specialists like Dr. Fritz Leutmezer at Wiener Privatklinik are deeply involved in university research. This bridge between private care and the Medical University of Vienna helps patients. They can access clinical trials usually reserved for domestic residents. Unlike clinics in other regions, Vienna focuses on haematopoietic stem cell transplantation for highly active cases.
Patient Consensus: Patients value the high-level neurology expertise in Vienna. However, they note that evaluations are thorough and time-consuming. Patients should confirm if a protocol is an official trial before travelling.
The Austrian MS Therapy Registry (AMSTR) evaluates real-world data on multiple sclerosis treatments. It tracks patient outcomes, medication side effects, and relapse history across over 100 Austrian centres. This nationwide database monitors treatment quality and secures government reimbursement for approved therapies.
Bookimed Expert Insight: Leading neurologists in Vienna, such as Dr Fritz Leutmezer at Wiener Privatklinik, use AMSTR data. They use this information to refine European treatment guidelines. Data from over 595,000 annual patients at Vienna General Hospital (AKH) strengthens the registry's reliability. Patients benefit as their care follows evidence-based protocols developed from these large datasets.
Patient Consensus: Patients in Austria note that joining the registry helps standardise their follow-up care. They also feel it provides quality assurance. They emphasise that while recording medication and relapse history is a data tool, it provides peace of mind.
Austria provides intensive neuro-rehabilitation and supportive therapies for Multiple Sclerosis (MS) using multidisciplinary teams. Centres integrate robotics, brain-computer interfaces, and traditional clinical methods. Specialists at facilities like Wiener Privatklinik and Vienna General Hospital (AKH) tailor programmes to manage spasticity and improve motor function.
Bookimed Expert Insight: Data shows a concentration of MS expertise in Vienna. Specialists like Dr Fritz Leutmezer lead both university research and private practice. Patients benefit from this dual role, as clinics often provide acupuncture alongside standard care. Choosing a centre with ISO certification, such as Private Hospital Lassnitzhöhe, provides international standards in neurological rehabilitation.
Patient Consensus: Patients in Austria value how physiotherapy and occupational therapy help maintain daily walking and hand function. They recommend asking for a plan that addresses fatigue management and swallowing issues. Including these alongside mobility support leads to the best results.